Total Payments
$11,167
2024 Payments
$807.72
Companies
19
Transactions
40
Medicare Patients
983
Medicare Billing
$89,844
Payment Breakdown by Category
Consulting$7,525 (67.4%)
Food & Beverage$1,542 (13.8%)
Other$1,275 (11.4%)
Travel$690.04 (6.2%)
Education$135.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,525 | 3 | 67.4% |
| Food and Beverage | $1,542 | 30 | 13.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,275 | 3 | 11.4% |
| Travel and Lodging | $690.04 | 2 | 6.2% |
| Education | $135.00 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $7,740 | 8 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $860.68 | 5 | $0 (2023) |
| BeiGene USA, Inc. | $675.00 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $525.00 | 2 | $0 (2017) |
| GENZYME CORPORATION | $208.80 | 3 | $0 (2024) |
| Seagen Inc. | $150.82 | 2 | $0 (2023) |
| Biocompatibles, Inc. | $141.59 | 1 | $0 (2017) |
| Blueprint Medicines Corporation | $124.99 | 1 | $0 (2022) |
| EISAI INC. | $124.99 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $114.98 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $807.72 | 5 | BeiGene USA, Inc. ($675.00) |
| 2023 | $1,721 | 13 | Bayer Healthcare Pharmaceuticals Inc. ($1,370) |
| 2022 | $6,745 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($6,370) |
| 2021 | $135.00 | 2 | Janssen Biotech, Inc. ($90.00) |
| 2020 | $319.52 | 5 | Seagen Inc. ($125.00) |
| 2019 | $22.78 | 1 | Novartis Pharmaceuticals Corporation ($22.78) |
| 2017 | $1,417 | 4 | Pharmacyclics LLC, An AbbVie Company ($750.00) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Oncology | ||||||
| 06/12/2024 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $57.21 | General |
| Category: Hematology | ||||||
| 02/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: Immunology | ||||||
| 10/25/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: ONCOLOGY | ||||||
| 10/13/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Oncology | ||||||
| 09/28/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Oncology | ||||||
| 09/26/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Oncology | ||||||
| 08/31/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: ONCOLOGY | ||||||
| 08/25/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.02 | General |
| 08/17/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ONCOLOGY | ||||||
| 06/30/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| Category: Oncology | ||||||
| 05/23/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2023 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $92.01 | General |
| 03/30/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Oncology | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $5,480.00 | General |
| Category: Oncology | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $398.16 | General |
| Category: Oncology | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $72.15 | General |
| Category: Oncology | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $61.46 | General |
| Category: Oncology | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $36.56 | General |
| Category: Oncology | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: Oncology | ||||||
| 10/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Travel and Lodging | In-kind items and services | $291.88 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 230 | 357 | $87,105 | $17,040 |
| 2022 | 8 | 289 | 560 | $152,190 | $26,750 |
| 2021 | 8 | 313 | 554 | $153,102 | $30,409 |
| 2020 | 7 | 151 | 254 | $63,317 | $15,645 |
Total Patients
983
Total Services
1,725
Medicare Billing
$89,844
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 17 | 25 | $5,375 | $1,091 | 20.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 11 | 12 | $1,332 | $523.17 | 39.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 13 | $1,625 | $400.25 | 24.6% |
About Dr. Chien-Shing Chen, M.D
Dr. Chien-Shing Chen, M.D is a Medical Oncology healthcare provider based in Loma Linda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073542692.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chien-Shing Chen, M.D has received a total of $11,167 in payments from pharmaceutical and medical device companies, with $807.72 received in 2024. These payments were reported across 40 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($7,525).
As a Medicare-enrolled provider, Chen has provided services to 983 Medicare beneficiaries, totaling 1,725 services with total Medicare billing of $89,844. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location Loma Linda, CA
- Active Since 07/03/2006
- Last Updated 07/16/2008
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1073542692
Products in Payments
- Nubeqa (Drug) $7,740
- Imbruvica (Drug) $789.58
- BRUKINSA (Drug) $675.00
- TAGRISSO (Drug) $525.00
- IMBRUVICA (Drug) $186.08
- ADCETRIS (Biological) $150.82
- THERASPHERE - BIO (Device) $141.59
- CABLIVI (Biological) $125.00
- AYVAKIT (Drug) $124.99
- Lenvima (Drug) $124.99
- KEYTRUDA (Biological) $87.79
- NERLYNX (Drug) $59.68
- ENJAYMO (Biological) $57.21
- TAZVERIK (Drug) $45.00
- Fabhalta (Drug) $32.10
- SARCLISA (Biological) $26.59
- ADAKVEO (Biological) $22.78
- Xospata (Drug) $19.46
- VERZENIO (Drug) $19.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.